InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
4
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-24.4%
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Milne George M Jr, 董事. Officer active across 4 companies, notably CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. In total, 11 disclosures have been published. Split: 4 buys · 1 sell. Total volume traded: €1.9m. Activity tracked since 7 May 2021. The latest transaction was filed on 12 January 2026 (Don). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Milne George M Jr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
17,780 股0Common StockSEC:0001193125-26-012921:0
27,910 股0Common StockSEC:0000950170-25-009913:0
100,000 股@ US$2.1989.6% 占其流量Common StockSEC:0000950170-24-104186:0
标准退出：2024年12月2日 (T+90)
9,100 股0Common StockSEC:0000950170-24-008347:0
94,350 股0Common StockSEC:0000950170-24-005437:0
8,733 股Common StockSEC:0001600620-23-000019:0
33,084 股@ US$31.855347.9% 占其流量Common StockSEC:0000899243-23-009179:0
20,000 股@ US$8.914277.4% 占其流量Common StockSEC:0001628280-23-006533:0
标准退出：2023年5月31日 (T+90)
5,000 股@ US$10.820.0023% mcap100.0% 占其流量Common StockSEC:0001628280-22-005381:0
标准退出：2022年6月2日 (T+90)
26,315 股@ US$19.0027.0% 占其流量Common StockSEC:0000899243-22-001521:0
标准退出：2022年4月6日 (T+90)
355 股0Common StockSEC:0001127602-21-016113:0
11 条申报中的 11 条
About Milne George M Jr
George M. Milne Jr. is a Director at Charles River Laboratories International, Inc. and Amylyx Pharmaceuticals, Inc. In this role, he participates in the governance and strategic direction of these companies. George brings his expertise to help guide decisions that support the mission and objectives of Charles River and Amylyx.
